Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy

Details for Australian Patent Application No. 2007329512 (hide)

Owner Novartis AG

Inventors Jeyaseelan, Jey Raju; Abe, Mie

Agent Davies Collison Cave

Pub. Number AU-A-2007329512

PCT Pub. Number WO2008/070552

Priority 60/872,326 01.12.06 US

Filing date 30 November 2007

Wipo publication date 12 June 2008

International Classifications

A61K 31/433 (2006.01) - Thiadiazoles

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/070552 Priority application(s): WO2008/070552

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007329516-Direct drive endoscopy systems and methods

2007329499-Method and apparatus for generating toxicology reports